Swiss drug makers Lonza and Roche agreed in March to the sale the Vacaville campus in the heart of Solano County’s burgeoning ...

This story first appeared in The Readout newsletter. Sign up for The Readout and receive STAT’s award-winning biotech news delivered straight to your inbox. This newsletter was penned in ...

October 09, 2024, 6:27 PM ESTCommercial Real Estate July 18, 2024, 9:37 AM ESTHealth Care March 06, 2024, 2:50 PM ESTHealth Care June 16, 2022, 4:42 PM ESTHealth Care May 18, 2021, 3:28 PM ...

Located in Metro Portland’s ‘Silicon Forest,’ the campus is proximate to a cluster of high profile companies including Intel, ...

It has shifted commercial manufacturing off Genentech's South San Francisco campus, cut hundreds of jobs, broken up its cancer immunology group and pared programs. The company, which employs about ...

A $1.2 billion deal by Swiss biotech firm Lonza to purchase the Vacaville Genentech site from Roche has been finalized, the firm announced Tuesday, securing 750 biotech jobs in Vacaville.

Off Campus is a TV adaptation of the book series by Elle Kennedy. Amazon Prime Video is soon going to adapt it, starting with the first book, The Deal. The "Off Campus" book series has been a ...

Elle Kennedy’s “Off-Campus” books are getting the screen treatment from Amazon Prime Video, which has ordered a series adaptation of the romance novels. Louisa Levy (“Death and Other ...

Image shows Roche’s head office in California, USA. Credit: Michael Vi via Shutterstock. Genentech is strengthening its oncology pipeline by acquiring Regor Pharmaceuticals’ portfolio of breast cancer ...

Genentech, a subsidiary of Roche, has laid down $850m for Regor Pharmaceuticals’ portfolio of next-generation CDK inhibitors for the treatment of breast cancer. The deal positions Genentech to lead ...

Genentech is paying $850 million upfront for Regor Pharmaceuticals’ portfolio of CDK inhibitors, taking ownership of a breast cancer candidate that has shown signs of single-agent efficacy in ...

(RTTNews) - Regor Pharmaceuticals USA has entered into a definitive purchase agreement, under which Genentech, a member of the Roche Group, will acquire a portfolio of next-generation CDK ...